Maryland SB490 prohibits the Maryland Medical Assistance Program from using step therapy or fail-first protocols for prescription drugs treating.

Maryland SB490 amends the Maryland Medical Assistance Program to prohibit the use of step therapy or fail-first protocols for prescription drugs treating serious mental illnesses, including bipolar disorder, schizophrenia, major depression, post-traumatic stress disorder, and medication-induced movement disorders. Beginning July 1, 2026, the program must require prior authorization instead of step therapy or fail-first protocols for these conditions. The law will remain in effect until June 30, 2029, after which it will be abrogated.

Maryland SB490 prohibits the Maryland Medical Assistance Program from using step therapy or fail-first protocols for prescription drugs treating.

Maryland SB490 amends the Maryland Medical Assistance Program to prohibit the use of step therapy or fail-first protocols for prescription drugs treating serious mental illnesses, including bipolar disorder, schizophrenia, major depression, post-traumatic stress disorder, and medication-induced movement disorders. Beginning July 1, 2026, the program must require prior authorization instead of step therapy or fail-first protocols for these conditions. The law will remain in effect until June 30, 2029, after which it will be abrogated.